BR112019001052A2 - composição farmacêutica tópica para promover crescimento capilar e/ou reduzir perda de cabelo - Google Patents
composição farmacêutica tópica para promover crescimento capilar e/ou reduzir perda de cabeloInfo
- Publication number
- BR112019001052A2 BR112019001052A2 BR112019001052A BR112019001052A BR112019001052A2 BR 112019001052 A2 BR112019001052 A2 BR 112019001052A2 BR 112019001052 A BR112019001052 A BR 112019001052A BR 112019001052 A BR112019001052 A BR 112019001052A BR 112019001052 A2 BR112019001052 A2 BR 112019001052A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- growth
- topical pharmaceutical
- growth factor
- hair loss
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/178—Lectin superfamily, e.g. selectins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/983—Blood, e.g. plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Vascular Medicine (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
a invenção se refere a uma composição farmacêutica tópica para promover crescimento capilar e/ou reduzir perda de cabelo em um humano. em particular, a composição farmacêutica compreende: (a) quantidade terapeuticamente eficaz de componente plaquetário que inclui um concentrado de fator de crescimento compreendendo fator de crescimento derivado de plaqueta (pgdf), fator de crescimento endotelial vascular (vegf), fator de crescimento de fibroblasto (fgf), e fator-ß de transformação do crescimento (tgf-ß); e (b) um agente intensificador da permeabilidade.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201621025016 | 2016-07-21 | ||
IN201621025017 | 2016-07-21 | ||
PCT/IN2017/050296 WO2018015973A1 (en) | 2016-07-21 | 2017-07-19 | Topical pharmaceutical composition for promoting hair growth and/or reducing hair loss |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112019001052A2 true BR112019001052A2 (pt) | 2019-04-30 |
Family
ID=60020259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112019001052A BR112019001052A2 (pt) | 2016-07-21 | 2017-07-19 | composição farmacêutica tópica para promover crescimento capilar e/ou reduzir perda de cabelo |
Country Status (5)
Country | Link |
---|---|
US (1) | US20190167763A1 (pt) |
EP (1) | EP3487520A1 (pt) |
CN (1) | CN109803671A (pt) |
BR (1) | BR112019001052A2 (pt) |
WO (1) | WO2018015973A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112675153A (zh) * | 2019-10-17 | 2021-04-20 | 上海萨美细胞技术有限公司 | 无细胞脂肪组织提取物促进毛发生长、固发的用途 |
US11491103B1 (en) * | 2020-07-02 | 2022-11-08 | Mahisha Jones | Hair growth formula |
CN116831983B (zh) * | 2023-09-02 | 2023-12-29 | 潍坊市人民医院(潍坊市公共卫生临床中心) | 一种浓缩生长因子复合凝胶制剂、制备方法及生发应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040197319A1 (en) | 2003-03-24 | 2004-10-07 | Paul Harch | Wound healing composition derived from low platelet concentration plasma |
US7931919B2 (en) | 2005-08-12 | 2011-04-26 | The United States Of America As Represented By The Secretary Of The Army | Method of producing glycine-stabilized, lyophilized plasma |
WO2009049318A2 (en) | 2007-10-12 | 2009-04-16 | Bakaltcheva Irina B | Freeze-dried plasma formats for the trauma care field |
US20110195112A1 (en) * | 2008-06-30 | 2011-08-11 | Bjorn Larus Orvar | Use of plant-derived recombinant growth factors in skin care |
US9227089B1 (en) | 2009-01-14 | 2016-01-05 | Pgfx Patent Holdings, Llc | Skin treatment for promoting hair growth |
CA2785631A1 (en) * | 2010-01-06 | 2011-07-14 | Orf Liftaekni Hf. | Method of use of stabilized plant-derived growth factor in skin care |
ES2402144T3 (es) * | 2010-05-25 | 2013-04-29 | Gwowei Technology Co., Ltd. | Lisado plaquetario inactivado que contiene factores de crecimiento empobrecido en PDGF y VEGF y su procedimiento de preparación |
TWI422385B (zh) | 2010-10-06 | 2014-01-11 | Central Medical Technologies Inc | Hair growth agent containing platelet dry powder |
US20190160103A1 (en) | 2011-07-14 | 2019-05-30 | Stefania GARBIN | Platelet-rich plasma composition for tissue repair and regeneration |
EP2628484B9 (en) | 2012-02-17 | 2016-08-17 | Opko Lab Europe Sl. | Platelet-rich plasma compositions |
US9445980B2 (en) * | 2012-04-18 | 2016-09-20 | Mark Laney | Methods for stimulating hair growth |
WO2013190567A2 (en) * | 2012-06-19 | 2013-12-27 | Shome Debraj | Composition and method for an intradermal hair growth solution |
WO2014027363A1 (en) * | 2012-08-17 | 2014-02-20 | Kasiak Research Pvt. Ltd. | A growth factor concentrate for treating hair loss |
EP2897689A4 (en) | 2012-09-24 | 2016-03-30 | Cormatrix Cardiovascular Inc | COMPOSITIONS AND METHODS OF TREATING ALOPEZIA |
WO2014184173A1 (en) * | 2013-05-14 | 2014-11-20 | Montero Gida Sanayi Ve Ticaret A.S. | Hair care formulations |
CN105287633A (zh) * | 2015-11-25 | 2016-02-03 | 沈政 | 一种促进头发生长的制剂、其制备方法及应用 |
-
2017
- 2017-07-19 WO PCT/IN2017/050296 patent/WO2018015973A1/en unknown
- 2017-07-19 US US16/318,354 patent/US20190167763A1/en not_active Abandoned
- 2017-07-19 CN CN201780044394.2A patent/CN109803671A/zh not_active Withdrawn
- 2017-07-19 EP EP17780217.0A patent/EP3487520A1/en not_active Withdrawn
- 2017-07-19 BR BR112019001052A patent/BR112019001052A2/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP3487520A1 (en) | 2019-05-29 |
CN109803671A (zh) | 2019-05-24 |
US20190167763A1 (en) | 2019-06-06 |
WO2018015973A1 (en) | 2018-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112017009807A2 (pt) | métodos e formulações para tratamento de doenças oculares vasculares | |
BR112018004532A2 (pt) | uso de akkermansia pasteurizado para o tratamento de distúrbios metabólicos | |
CO2017009954A2 (es) | Dominios diseñados con repeticiones de anquirina con especificidad de unión para la seroalbúmina | |
BR112017017009A2 (pt) | usos de um sequestrante de formaldeído e de uma composição farmacêutica, métodos para impedir, adiar, retardar ou diminuir a transformação de um composto e para tratar câncer, e, composição farmacêutica. | |
BR112015030514A2 (pt) | Composições e métodos para conjugação de anticorpos ativáveis | |
BR112017026294A2 (pt) | formulação em gel tópica farmacêutica, e, método para tratar ou prevenir uma doença ou condição. | |
TR201901077T4 (tr) | Kanser Veya Enfeksiyon Tedavisine Yönelik Birleşik Preparasyonlar | |
BR112019001052A2 (pt) | composição farmacêutica tópica para promover crescimento capilar e/ou reduzir perda de cabelo | |
EA201491856A1 (ru) | Терапевтическое применение белков фактора роста фибробластов 21 | |
BR112018003892A2 (pt) | ?composição farmacêutica e método para a redução da gordura? | |
BR112015031417A2 (pt) | forma de dosagem farmacêutica, composição farmacêutica, métodos para tratamento de um paciente com necessidade de cisteamina e para preparo de uma forma de dosagem | |
BR112017023391A2 (pt) | ?composição, método para preparar uma composição e métodos para melhorar a hidratação da pele? | |
BR112014021653A2 (pt) | Formulação tópica, método para tratamento de feridas e método para fabricar uma formulação tópica | |
BR112015015108A2 (pt) | cateter com marcações para facilitar o alinhamento | |
MX2018002924A (es) | Anticuerpos monoclonales altamente potentes para factores angiogenicos. | |
BR112017005828A2 (pt) | métodos para tratar ou prevenir uma infecção respiratória, copd e uma exacerbação de copd e para selecionar um inibidor de sinalização notch 3 e/ou notch4, usp de um inibidor de sinalização de notch 3 e/ou notch 4, inibidor de sinalização de notch 3 e/ou notch 4, e, composição farmacêutica. | |
BR112019023260A2 (pt) | Fatores de crescimento de fibroblastos recombinantes modificados e seus usos terapêuticos | |
BR112018067554A2 (pt) | formulações de testosterona e métodos de tratamento com as mesmas | |
BR102015001449B8 (pt) | composição de gel dental de papaína para tratamento não traumático de cáries e método para seu preparo | |
BR112016000092A2 (pt) | nanopartículas lipídicas para a cicatrização de feridas | |
BR112017023762A2 (pt) | formulações de depósito injetáveis | |
BR112018001791A2 (pt) | antitranspirante | |
BR112015027992A2 (pt) | uso de ácido petroselínico para combater desordens estéticas da figura do corpo | |
BR112019001130A2 (pt) | uso de lactama e composição farmacêutica | |
BR112015023368A2 (pt) | método de tratamento de deficiência de vitamina b12 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2679 DE 10-05-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |